These results for NfL are in agreement with a meta‐analysis by Sferruzza et al,34 which included multiple studies that investigated blood and CSF NfL concentrations and evaluated their ability to distinguish ALS patients from ALS mimic disorders. The gene discussed is NEFL; the disease is amyotrophic lateral sclerosis.